Search

Donna C. Wortman

Examiner (ID: 7433)

Most Active Art Unit
1648
Art Unit(s)
1648, 1621, 1643, 1645, 1815, 1802, 1813
Total Applications
641
Issued Applications
379
Pending Applications
76
Abandoned Applications
186

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1474080 [patent_doc_number] => 06387662 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Synthesis and purification of hepatitis C virus-like particles' [patent_app_type] => B1 [patent_app_number] => 09/296441 [patent_app_country] => US [patent_app_date] => 1999-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 11507 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387662.pdf [firstpage_image] =>[orig_patent_app_number] => 09296441 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/296441
Synthesis and purification of hepatitis C virus-like particles Apr 20, 1999 Issued
Array ( [id] => 4136092 [patent_doc_number] => 06121420 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Diagnosis of fungal infections, and a chitin-binding lectin useful in such diagnoses' [patent_app_type] => 1 [patent_app_number] => 9/290836 [patent_app_country] => US [patent_app_date] => 1999-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8441 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121420.pdf [firstpage_image] =>[orig_patent_app_number] => 290836 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/290836
Diagnosis of fungal infections, and a chitin-binding lectin useful in such diagnoses Apr 12, 1999 Issued
Array ( [id] => 4346252 [patent_doc_number] => 06214567 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Immortalized human keratinocyte cell line' [patent_app_type] => 1 [patent_app_number] => 9/277295 [patent_app_country] => US [patent_app_date] => 1999-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 15314 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214567.pdf [firstpage_image] =>[orig_patent_app_number] => 277295 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/277295
Immortalized human keratinocyte cell line Mar 25, 1999 Issued
Array ( [id] => 4366164 [patent_doc_number] => 06287761 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Synthetic antigens for the detection of antibodies to hepatitis C virus' [patent_app_type] => 1 [patent_app_number] => 9/275265 [patent_app_country] => US [patent_app_date] => 1999-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 12470 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287761.pdf [firstpage_image] =>[orig_patent_app_number] => 275265 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/275265
Synthetic antigens for the detection of antibodies to hepatitis C virus Mar 22, 1999 Issued
Array ( [id] => 4284611 [patent_doc_number] => 06268124 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Neuronal cell model and methods of use therefor' [patent_app_type] => 1 [patent_app_number] => 9/272158 [patent_app_country] => US [patent_app_date] => 1999-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9059 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268124.pdf [firstpage_image] =>[orig_patent_app_number] => 272158 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/272158
Neuronal cell model and methods of use therefor Mar 18, 1999 Issued
Array ( [id] => 4273230 [patent_doc_number] => 06280940 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease' [patent_app_type] => 1 [patent_app_number] => 9/263933 [patent_app_country] => US [patent_app_date] => 1999-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 48385 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/280/06280940.pdf [firstpage_image] =>[orig_patent_app_number] => 263933 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/263933
Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease Mar 7, 1999 Issued
09/262614 METHOD OF DETECTING THE PRESENCE OF CD155 FOR DIAGNOSIS OF CANCER AND TO DETERMINE TREATMENT Mar 3, 1999 Abandoned
Array ( [id] => 4349304 [patent_doc_number] => 06291226 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Adenovirus mutants with deleted protease gene' [patent_app_type] => 1 [patent_app_number] => 9/258209 [patent_app_country] => US [patent_app_date] => 1999-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 9248 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291226.pdf [firstpage_image] =>[orig_patent_app_number] => 258209 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/258209
Adenovirus mutants with deleted protease gene Feb 24, 1999 Issued
Array ( [id] => 6176251 [patent_doc_number] => 20020155552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => '\"PRIONINS\", HIGHLY SPECIFIC MARKERS FOR NONINVASIVE PRE-SYMPTOMATIC DETECTION OF TSE DISEASES, AND TARGETS FOR THERAPEUTIC REAGENTS TO PREVENT AND CONTROL TSE DISEASES IN ANIMALS AND HUMANS' [patent_app_type] => new [patent_app_number] => 09/242450 [patent_app_country] => US [patent_app_date] => 1999-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8315 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155552.pdf [firstpage_image] =>[orig_patent_app_number] => 09242450 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/242450
PRIONINS", HIGHLY SPECIFIC MARKERS FOR NONINVASIVE PRE-SYMPTOMATIC DETECTION OF TSE DISEASES, AND TARGETS FOR THERAPEUTIC REAGENTS TO PREVENT AND CONTROL TSE DISEASES IN ANIMALS AND HUMANS Feb 15, 1999 Abandoned
Array ( [id] => 4401131 [patent_doc_number] => 06231864 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Strategically modified hepatitis B core proteins and their derivatives' [patent_app_type] => 1 [patent_app_number] => 9/248588 [patent_app_country] => US [patent_app_date] => 1999-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13826 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/231/06231864.pdf [firstpage_image] =>[orig_patent_app_number] => 248588 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/248588
Strategically modified hepatitis B core proteins and their derivatives Feb 10, 1999 Issued
Array ( [id] => 4270026 [patent_doc_number] => 06280728 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Treatment of hepatitis C virus infection using a protease and a flavonoid' [patent_app_type] => 1 [patent_app_number] => 9/245820 [patent_app_country] => US [patent_app_date] => 1999-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 1925 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/280/06280728.pdf [firstpage_image] =>[orig_patent_app_number] => 245820 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/245820
Treatment of hepatitis C virus infection using a protease and a flavonoid Feb 4, 1999 Issued
Array ( [id] => 4410244 [patent_doc_number] => 06228846 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Polynucleotide vaccine formula against canine pathologies' [patent_app_type] => 1 [patent_app_number] => 9/232477 [patent_app_country] => US [patent_app_date] => 1999-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5290 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228846.pdf [firstpage_image] =>[orig_patent_app_number] => 232477 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/232477
Polynucleotide vaccine formula against canine pathologies Jan 14, 1999 Issued
Array ( [id] => 4325933 [patent_doc_number] => 06319726 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Immunological method for detecting antibodies directed against tissue transglutaminase (tTG), use of tTG in diagnosis and therapy control, and an oral pharmaceutical agent containing tTG' [patent_app_type] => 1 [patent_app_number] => 9/229716 [patent_app_country] => US [patent_app_date] => 1999-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6829 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319726.pdf [firstpage_image] =>[orig_patent_app_number] => 229716 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/229716
Immunological method for detecting antibodies directed against tissue transglutaminase (tTG), use of tTG in diagnosis and therapy control, and an oral pharmaceutical agent containing tTG Jan 12, 1999 Issued
Array ( [id] => 7640442 [patent_doc_number] => 06395471 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Hepatitis C surrogate virus for testing the activity of hepatitis C virus protease, a recombinant gene and a use thereof' [patent_app_type] => B1 [patent_app_number] => 09/202904 [patent_app_country] => US [patent_app_date] => 1998-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 4509 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395471.pdf [firstpage_image] =>[orig_patent_app_number] => 09202904 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/202904
Hepatitis C surrogate virus for testing the activity of hepatitis C virus protease, a recombinant gene and a use thereof Dec 22, 1998 Issued
Array ( [id] => 4309227 [patent_doc_number] => 06316252 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Biotherapeutic delivery system' [patent_app_type] => 1 [patent_app_number] => 9/213343 [patent_app_country] => US [patent_app_date] => 1998-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3898 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316252.pdf [firstpage_image] =>[orig_patent_app_number] => 213343 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/213343
Biotherapeutic delivery system Dec 16, 1998 Issued
Array ( [id] => 1373910 [patent_doc_number] => 06558899 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-06 [patent_title] => 'Method for identifying new anti-picornaviral compounds' [patent_app_type] => B1 [patent_app_number] => 09/210118 [patent_app_country] => US [patent_app_date] => 1998-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5091 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/558/06558899.pdf [firstpage_image] =>[orig_patent_app_number] => 09210118 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/210118
Method for identifying new anti-picornaviral compounds Dec 10, 1998 Issued
Array ( [id] => 4416789 [patent_doc_number] => 06177076 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Method of treating bladder cancer with wild type vaccinia virus' [patent_app_type] => 1 [patent_app_number] => 9/206425 [patent_app_country] => US [patent_app_date] => 1998-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1895 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177076.pdf [firstpage_image] =>[orig_patent_app_number] => 206425 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/206425
Method of treating bladder cancer with wild type vaccinia virus Dec 6, 1998 Issued
Array ( [id] => 4260708 [patent_doc_number] => 06258788 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'DNA vaccines against tick-borne flaviviruses' [patent_app_type] => 1 [patent_app_number] => 9/197218 [patent_app_country] => US [patent_app_date] => 1998-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 11612 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258788.pdf [firstpage_image] =>[orig_patent_app_number] => 197218 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/197218
DNA vaccines against tick-borne flaviviruses Nov 19, 1998 Issued
09/187057 HUMAN PAN-HCV HUMAN MONOCLONAL ANTIBODIES Nov 4, 1998 Abandoned
Array ( [id] => 4349612 [patent_doc_number] => 06291246 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'DNA virus vectors and methods for their preparation' [patent_app_type] => 1 [patent_app_number] => 9/184987 [patent_app_country] => US [patent_app_date] => 1998-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7149 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291246.pdf [firstpage_image] =>[orig_patent_app_number] => 184987 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/184987
DNA virus vectors and methods for their preparation Nov 2, 1998 Issued
Menu